Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures
暂无分享,去创建一个
Michael Famulok | Günter Mayer | Andreas Dolf | M. Famulok | E. Endl | P. Knolle | A. Dolf | G. Mayer | Elmar Endl | Percy A Knolle | Marie-Sophie L Ahmed | Marie-Sophie L. Ahmed
[1] G. Mayer,et al. Evolution of specific RNA motifs derived from pan-protein interacting precursors. , 2010, Bioorganic & medicinal chemistry letters.
[2] Mario Roederer,et al. Quality assurance for polychromatic flow cytometry , 2006, Nature Protocols.
[3] Michael Famulok,et al. Molecular Recognition of Amino Acids by RNA-Aptamers: An L-Citrulline Binding RNA Motif and Its Evolution into an L-Arginine Binder , 1994 .
[4] P. Burgstaller,et al. Isolation of RNA Aptamers for Biological Cofactors by In Vitro Selection , 1994 .
[5] D. Shangguan,et al. Development of DNA aptamers using Cell-SELEX , 2010, Nature Protocols.
[6] F. Ducongé,et al. Metastasis‐focused cell‐based SELEX generates aptamers inhibiting cell migration and invasion , 2011, International journal of cancer.
[7] M. Famulok,et al. Generation and enzymatic amplification of high-density functionalized DNA double strands. , 2004, Angewandte Chemie.
[8] D. Neri,et al. Antibody-based targeting of the tumor vasculature. , 2007, Biochimica et biophysica acta.
[9] J. M. Healy,et al. Complex Target SELEX , 2008 .
[10] Gerhard Ziemer,et al. A New Technique for the Isolation and Surface Immobilization of Mesenchymal Stem Cells from Whole Bone Marrow Using High‐Specific DNA Aptamers , 2006, Stem cells.
[11] D. Neri,et al. An engineered antibody–interleukin‐12 fusion protein with enhanced tumor vascular targeting properties , 2006, International journal of cancer.
[12] D. Patel,et al. Adaptive recognition by nucleic acid aptamers. , 2000, Science.
[13] G. Mayer,et al. In vitro selection of ssDNA aptamers using biotinylated target proteins. , 2009, Methods in molecular biology.
[14] D. S. Coffey,et al. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. , 2002, Cancer research.
[15] Dario Neri,et al. Engineering recombinant antibodies for immunotherapy , 1995, Cell Biophysics.
[16] N. Becker,et al. Sequence-specific binding of DNA and RNA to immobilized Nickel ions. , 2008, Biochemical and biophysical research communications.
[17] Weihong Tan,et al. Selection of DNA ligands for protein kinase C-delta. , 2006, Chemical communications.
[18] Larry Gold,et al. Proteomics and diagnostics: Let's Get Specific, again. , 2008, Current opinion in chemical biology.
[19] M. Famulok,et al. Prion‐Protein‐Specific Aptamer Reduces PrPSc Formation , 2002, Chembiochem : a European journal of chemical biology.
[20] L. Cassiday,et al. Crystal structure of NF-kappaB (p50)2 complexed to a high-affinity RNA aptamer. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[21] Michael Famulok,et al. RNA ligands that distinguish metabolite-induced conformations in the TPP riboswitch. , 2007, Angewandte Chemie.
[22] Jeff Zimmerman,et al. Crystal structure of NF-κB (p50)2 complexed to a high-affinity RNA aptamer , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[23] Michael Famulok,et al. Conformational changes in the expression domain of the Escherichia coli thiM riboswitch , 2007, Nucleic acids research.
[24] Ying-Fon Chang,et al. Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein* , 2001, The Journal of Biological Chemistry.
[25] Gwendolyn M. Stovall,et al. Technical and biological issues relevant to cell typing with aptamers. , 2009, Journal of proteome research.
[26] Gerhard Ziemer,et al. Streptavidin-coated magnetic beads for DNA strand separation implicate a multitude of problems during cell-SELEX. , 2009, Oligonucleotides.
[27] T. Steitz,et al. The structure of HIV‐1 reverse transcriptase complexed with an RNA pseudoknot inhibitor , 1998, The EMBO journal.
[28] Michael Famulok,et al. A versatile toolbox for variable DNA functionalization at high density. , 2005, Journal of the American Chemical Society.
[29] M. Famulok,et al. Secondary structures and functional requirements for thiM riboswitches from Desulfovibrio vulgaris, Erwinia carotovora and Rhodobacter spheroides , 2008, Biological chemistry.
[30] J. McNamara,et al. Cell-specific aptamers for targeted therapies. , 2009, Methods in molecular biology.
[31] M. Famulok,et al. An aptamer targeting the apical-loop domain modulates pri-miRNA processing. , 2010, Angewandte Chemie.
[32] Bertrand Tavitian,et al. Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase , 2005, PLoS biology.
[33] Michael Famulok,et al. A Y2 Receptor Mimetic Aptamer Directed against Neuropeptide Y* , 2002, The Journal of Biological Chemistry.
[34] M. Famulok,et al. Functionalized DNA: A New Replicable Biopolymer. , 2001, Angewandte Chemie.
[35] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[36] M. Famulok,et al. RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of beta-secretase BACE1 in vitro. , 2006, RNA.
[37] H. Schluesener,et al. Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels , 2001, The Journal of Biological Chemistry.
[38] A. Ellington,et al. Directed evolution of gold nanoparticle delivery to cells. , 2010, Chemical communications.
[39] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[40] Michael Famulok,et al. Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. , 2008, Angewandte Chemie.
[41] D. Neri,et al. Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy , 2008, Clinical Cancer Research.
[42] Günter Mayer,et al. From selection to caged aptamers: identification of light-dependent ssDNA aptamers targeting cytohesin. , 2009, Bioorganic & medicinal chemistry letters.
[43] Michael Famulok,et al. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. , 2007, Chemical reviews.
[44] Michael Famulok,et al. In vivo-applied functional RNAs as tools in proteomics and genomics research. , 2002, Trends in biotechnology.
[45] M. Lohse,et al. An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro. , 2008, RNA.
[46] P. Cramer,et al. Structure of an RNA polymerase II–RNA inhibitor complex elucidates transcription regulation by noncoding RNAs , 2006, Nature Structural &Molecular Biology.
[47] E. Gilboa,et al. Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay , 2010, Nature.
[48] Holden T Maecker,et al. Flow cytometry controls, instrument setup, and the determination of positivity , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[49] G. Mayer. The chemical biology of aptamers. , 2009, Angewandte Chemie.
[50] F. Eckstein,et al. Modified oligonucleotides: synthesis and strategy for users. , 1998, Annual review of biochemistry.
[51] Jack W. Szostak,et al. An RNA motif that binds ATP , 1993, Nature.
[52] D. Neri,et al. Antibodies from phage display libraries as immunochemical reagents. , 1998, Methods in molecular biology.